Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Invested Capital (2020 - 2023)

Terns Pharmaceuticals' Return on Invested Capital history spans 4 years, with the latest figure at 0.32% for Q3 2023.

  • For Q3 2023, Return on Invested Capital rose 5.0% year-over-year to 0.32%; the TTM value through Sep 2023 reached 0.32%, up 5.0%, while the annual FY2022 figure was 0.29%, 152.0% up from the prior year.
  • Return on Invested Capital reached 0.32% in Q3 2023 per TERN's latest filing, down from 0.26% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.1% in Q4 2020 to a low of 1.24% in Q1 2021.
  • Average Return on Invested Capital over 4 years is 0.35%, with a median of 0.3% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: tumbled -41bps in 2021, then soared 91bps in 2022.
  • A 4-year view of Return on Invested Capital shows it stood at 0.1% in 2020, then crashed by -395bps to 0.3% in 2021, then rose by 10bps to 0.27% in 2022, then decreased by -20bps to 0.32% in 2023.
  • Per Business Quant, the three most recent readings for TERN's Return on Invested Capital are 0.32% (Q3 2023), 0.26% (Q2 2023), and 0.25% (Q1 2023).